Y-Intercept (HK)’s Mural Oncology MURA Stock Holding History

Y-Intercept (HK)’s Portfolio MURA Stock Details MURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-15,004	Closed	-$47.1K	–	1623
2024 Q2	$47.1K	Buy	+15,004	New	+$55.3K	﹤0.01%	1303

Other funds holding MURA

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

SCM

Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AFA

Alta Fundamental Advisers New York $265M AUM 98.61% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Y-Intercept (HK)'s MURA Position: Q3 2024 in Review

Y-Intercept (HK) sold out of Mural Oncology (MURA) in Q3 2024, closing a stake of 15,004 shares — an estimated $47.1K sold.

Y-Intercept (HK) first reported a position in MURA in Q2 2024 and held it in 1 quarter. The position peaked at $47.1K in Q2 2024. 74 funds tracked by Wall St. Rank hold MURA as of Q3 2024.

Y-Intercept (HK) reported no remaining Mural Oncology position as of Q3 2024 after selling out during the quarter.
Y-Intercept (HK) sold 15,004 Mural Oncology shares in Q3 2024, an estimated $47.1K.
Y-Intercept (HK) first reported a position in Mural Oncology in Q2 2024 and held it in 1 quarter.
Y-Intercept (HK)'s Mural Oncology position peaked at $47.1K in Q2 2024.
74 funds tracked by Wall St. Rank held Mural Oncology as of Q3 2024.

Based on Y-Intercept (HK)'s 13F filing for Q3 2024, filed 15 Nov 2024.